How the Brain Senses the World Inside

How the Brain Senses the World Inside

Science Changing Interoception

Science Changing Interoception

Interoception: A sense of self

Neuroscientists rapidly decode interoception, the long-overlooked links between our brain and the heart, stomach and other organs.

Science Changing Autism

Science Changing Autism

On the Spectrum of Hope

The future of autism spectrum disorders looks brighter, thanks to rapid advances in genomic sequencing technology and progress toward targeted, precision medicines.

Science Changing Alzheimer’s

Science Changing Alzheimer’s

Memory everlasting

How the Lottie French Lewis Fund supports early careers and Alzheimer’s research.

Science Changing Clinical Trials

Science Changing Clinical Trials

Re-engineering clinical trials

Advances in digital health technologies allow for continuous monitoring of behavioral and physiological metrics, such as heart rate, blood sugar, activity and sleep. Being able to collect longitudinal data on study participants gives scientists much more detailed insights into how their bodies are responding to any given intervention, enabling a more individualized approach to medicine.

President’s Letter

President Peter Schultz highlights the global, interconnected nature of science at Scripps Research

The beauty of science is that it can fulfill all these aspirations. The drive to understand nature—to decipher its most complex and elusive facets—provides the fresh, new ideas we need to overcome our greatest problems. Hard-won scientific knowledge is a powerful tool for improving people’s lives.

Read More

Translations


A new indication of success: FDA approves ozanimod for ulcerative colitis

Ozanimod, the drug invented at Scripps Research that won FDA approval last year for relapsing forms of multiple sclerosis, has been approved in the United States for a second high-need medical condition, ulcerative colitis.

Translations


Extensive study identifies over a dozen existing drugs as potential COVID-19 therapies

FDA-approved drugs or experimental drugs with ample health data could be rapidly tested in humans for treatment of COVID-19.

Awards & Honors

Biochemist Jeffery Kelly awarded 2022 Life Sciences Breakthrough Prize

Pioneering biochemist has been awarded a $3 million Breakthrough Prize for transformative advances in the understanding of neurological disease.

Read More View All
Jeffery Kelly, PhD. Credit: Scripps Research

Awards & Honors

David Goodsell named recipient of 2022 Fankuchen Memorial Award

The American Crystallographic Association has recognized Goodsell's “contributions to crystallographic research by one who is known to be an effective teacher of crystallography.”

Read More View All

Awards & Honors

Ed Roberts inducted into MEDI Hall of Fame by American Chemical Society

Roberts co-invented ozanimod (Zeposia®) with Scripps Research professor Hugh Rosen, MD, PhD, and their laboratory colleagues.

Read More View All

Awards & Honors

Benjamin Cravatt named recipient of 2021 Chemical Pioneer Award

In giving the honor, the institute said Cravatt’s work has “radically changed the standards of proteomics, resulting in innovative solutions to the creation of modern medicines.”

Read More View All

Awards & Honors

Hans Renata selected for Emerging Investigator Lectureship role

The role recognizes a researcher who has made a significant contribution to a natural products-related area of the chemical sciences in their early independent career.

Read More View All

Awards & Honors

Sharpless team receives Robert Robinson Award in Synthetic Organic Chemistry

The Royal Society of Chemistry has recognized Karl Barry Sharpless, PhD, and his team, along with their collaborators, for their development of a technology called “multidimensional click chemistry,” that has opened up new possibilities in biomedicine, materials science and other fields.

Read More View All

Awards & Honors

Jeffery Kelly named recipient of 2021 Edward E. Smissman Award

Kelly receives the honor for his seminal work on transthyretin and its contributions to the amyloid hypothesis.

Read More View All
Jeffery Kelly, PhD. Credit: Scripps Research

Awards & Honors

Michael Constantinides named winner of 2021 Young Investigator Award

The Donald E. and Delia B. Baxter Foundation has named Michael Constantinides, PhD, winner of its 2021 Young Investigator Award.

Read More View All

Awards & Honors

Janet Davison Rowley Patient Impact Research Award

Calibr, the drug discovery division of Scripps Research, is home to ReFRAME, the world’s leading collection of drugs known to be safe in humans. During the COVID-19 pandemic, the institute combed this collection to identify medicines that could be rapidly repurposed against the novel coronavirus.

Read More View All

Noteworthy

View All

Calibr partners with Wellcome Trust to create consortium for neglected tropical diseases

A $24 million grant will support Calibr in leveraging innovative approaches to address some of the most challenging neglected tropical diseases across the globe.

Read more

Noteworthy

View All

Scientists with diverse expertise to join Scripps Research faculty

Protein engineering, autism genetics and virology experts join the faculty, and a Scripps Research Fellow is promoted to assistant professor, in pursuit of new knowledge and treatments for unmet medical needs.

Read more

Noteworthy

View All

Scripps Research appoints global health advocate Lillian Lou to Board of Directors

Lou brings experience as a biopharma industry leader and a champion for accessible healthcare, as she carries on the legacy of life partner John C. Martin.

Read more

In the Spotlight

It takes guts


Investigating the power of symbiotic microorganisms to share health and medicine, with chemist Howard Hang, PhD.
Read More

Video Series

View All

Recent Discoveries

See All

Upcoming Edition

Welcome to Scripps Research Magazine online. This info-packed website showcases the ideas-driven science we are renowned for. If you prefer, subscribe to our award-winning print magazine.

Subscribe Now